Coverage · Recent News · Press Resources
In the news.
Recent coverage, announcements, and the resources journalists need to write about the work.
In the news.
- 2026
The Hillman Letter launches on Substack
New publication on FDA regulatory strategy, frontier therapeutics, and capital decisions in healthcare. Read at thehillmanletter.substack.com.
- 2026
Hillman Ventures marks 30 years of frontier biotech investing
The private family office founded in Dallas in 1995 continues its focus on inflammation, damaged tissue, and tumor-based cancer platforms grounded in FDA biologics pathway thinking.
- 2026
FixCancer.org launches public-facing TOL site
Targeted Osmotic Lysis explainer and mechanism walkthrough goes live. TOL is investigational, is not FDA-approved, and has no registered clinical trial. See fixcancer.org.
- 2025
Andrew Hillman Scholarship for Entrepreneurs
Live. A $1,000 essay-contest scholarship for undergraduate students on the path to an entrepreneurial career, open nationwide. Launched in March 2025. Apply at andrewhillmanscholarship.com. Coverage: National Law Review, The Globe and Mail. Also on andrewhillman.org/scholarship-2026/.
- 2026
Andrew Hillman Grant for Biotech
Live. A $1,000 essay-contest grant for undergraduate students building a career in biotechnology. Announced in February 2026. Applications for the 2027 cycle are now open. Apply at andrewhillmangrant.com. Coverage: Yahoo Finance, National Law Review.
In the news
Press releases and syndicated coverage.
The National Law Review
Yahoo Finance
- Announcement (healthcare)
- Launch announcement
- Launch announcement
- Scholarship opens doors
- Grant for Biotech opens
- Announcement
- Nationwide scholarship launch
- Grant for Biotech announcement
- Announcement (healthcare)
- National scholarship launch
- Nationwide scholarship announcement
The Globe and Mail (Newsfile)
Listings and directories: Andrew J. Hillman on LaunchRecord · Andrew J. Hillman on BubbleLife Uptown · Vista Hospital of Dallas (NPI registry record)
The Hillman Letter Podcast: Apple Podcasts · YouTube · All episodes and show notes
Profiles and channels: Medium · Pocket Casts · Bluesky · Gravatar · SpeakerHub · YouTube channel · IMDb
For journalists.
Press kit
Verified bio at three lengths, fact sheet, speaking topics, headshots, downloads. Open the press kit.
Public record
The primary-source operating record and timeline at andrewhillmanrecord.com. Verified directly, no PR filter.
Direct contact
For interviews, press, podcasts, and quote requests: contact@andrew-hillman.com. Direct response.
Topic depth
FDA biologics pathway, exosome regulatory science, family office structure, compliance, Dallas biotech ecosystem.
Exosome and mesenchymal stem cell-derived extracellular vesicle products are not approved by the FDA for any indication. References here describe published scientific literature. They do not describe an available treatment.
Andrew Jonathan Hillman
Dallas senior paralegal and healthcare compliance expert witness. Not an attorney.
Expert witness page · Publications · Videos · Book a meeting